Search research articles
Contact Us
Filters
Showing results (91-100 of 153) with videos related to
Page
of 16
Sort By:
Clinical Chemistry and Laboratory Medicine
|
October 26, 2022
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study
Antigona Ulndreaj, Davor Brinc, Mehmet Altan, et al.
Journal for Immunotherapy of Cancer
|
October 14, 2020
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
James Welsh, Hari Menon, Dawei Chen, et al.
NPJ Precision Oncology
|
June 26, 2026
Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology
Jennifer A Marks, Rohan Maniar, Kavitha J Ramchandran, et al.
Clinical Lung Cancer
|
August 25, 2024
Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis
Felipe Soto-Lanza, Lydia Glick, Colin Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2021
Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial
Yasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2023
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
Yousef R Badran, Fangwen Zou, Sienna M Durbin, et al.
Frontiers in Immunology
|
March 5, 2019
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
Hari Menon, Rishab Ramapriyan, Taylor R Cushman, et al.
Journal of Immunotherapy and Precision Oncology
|
April 16, 2025
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021
Mehmet Altan, Dawen Sui, Cai Xu, et al.
Oncoimmunology
|
December 21, 2023
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases
Pankti Reid, Sabina Sandigursky, Juhee Song, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 18, 2020
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC
Mark M Awad, Shirish M Gadgeel, Hossein Borghaei, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 153) with videos related to
Sort By:
Page
of 16
Clinical Chemistry and Laboratory Medicine
|
October 26, 2022
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study
Antigona Ulndreaj, Davor Brinc, Mehmet Altan, et al.
Journal for Immunotherapy of Cancer
|
October 14, 2020
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
James Welsh, Hari Menon, Dawei Chen, et al.
NPJ Precision Oncology
|
June 26, 2026
Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology
Jennifer A Marks, Rohan Maniar, Kavitha J Ramchandran, et al.
Clinical Lung Cancer
|
August 25, 2024
Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis
Felipe Soto-Lanza, Lydia Glick, Colin Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2021
Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial
Yasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2023
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
Yousef R Badran, Fangwen Zou, Sienna M Durbin, et al.
Frontiers in Immunology
|
March 5, 2019
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
Hari Menon, Rishab Ramapriyan, Taylor R Cushman, et al.
Journal of Immunotherapy and Precision Oncology
|
April 16, 2025
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021
Mehmet Altan, Dawen Sui, Cai Xu, et al.
Oncoimmunology
|
December 21, 2023
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases
Pankti Reid, Sabina Sandigursky, Juhee Song, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 18, 2020
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC
Mark M Awad, Shirish M Gadgeel, Hossein Borghaei, et al.
Page
of 16